Supporting these findings, myofibroblast-specific Hsp47-deleted mice also showed reduced cardiac hypertrophy after TAC compared with control mice, as assessed by echocardiography (Figure 5E). The gene discussed is SERPINH1; the disease is persistent truncus arteriosus.